NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 115 filers reported holding NURIX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $147,000 | -7.0% | 11,305 | -9.5% | 0.00% | – |
| Q2 2022 | $158,000 | +17.0% | 12,493 | +2.5% | 0.00% | – |
| Q1 2022 | $135,000 | -62.2% | 12,188 | -1.1% | 0.00% | – |
| Q4 2021 | $357,000 | -11.6% | 12,323 | -8.7% | 0.00% | – |
| Q3 2021 | $404,000 | +14.1% | 13,491 | +1.2% | 0.00% | – |
| Q2 2021 | $354,000 | -10.2% | 13,335 | +5.2% | 0.00% | – |
| Q1 2021 | $394,000 | +10.7% | 12,680 | +17.1% | 0.00% | – |
| Q4 2020 | $356,000 | -9.6% | 10,829 | -4.0% | 0.00% | -100.0% |
| Q3 2020 | $394,000 | – | 11,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |